Cargando…
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
BACKGROUND: The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In this paper we expand on the REMARK c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362748/ https://www.ncbi.nlm.nih.gov/pubmed/22642691 http://dx.doi.org/10.1186/1741-7015-10-51 |
_version_ | 1782234252122783744 |
---|---|
author | Altman, Douglas G McShane, Lisa M Sauerbrei, Willi Taube, Sheila E |
author_facet | Altman, Douglas G McShane, Lisa M Sauerbrei, Willi Taube, Sheila E |
author_sort | Altman, Douglas G |
collection | PubMed |
description | BACKGROUND: The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In this paper we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report. METHODS: REMARK recommends including a transparent and full description of research goals and hypotheses, subject selection, specimen and assay considerations, marker measurement methods, statistical design and analysis, and study results. Each checklist item is explained and accompanied by published examples of good reporting, and relevant empirical evidence of the quality of reporting. We give prominence to discussion of the 'REMARK profile', a suggested tabular format for summarizing key study details. SUMMARY: The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. To encourage dissemination of the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration, this article has also been published in PLoS Medicine. |
format | Online Article Text |
id | pubmed-3362748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33627482012-05-31 Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration Altman, Douglas G McShane, Lisa M Sauerbrei, Willi Taube, Sheila E BMC Med Correspondence BACKGROUND: The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In this paper we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report. METHODS: REMARK recommends including a transparent and full description of research goals and hypotheses, subject selection, specimen and assay considerations, marker measurement methods, statistical design and analysis, and study results. Each checklist item is explained and accompanied by published examples of good reporting, and relevant empirical evidence of the quality of reporting. We give prominence to discussion of the 'REMARK profile', a suggested tabular format for summarizing key study details. SUMMARY: The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. To encourage dissemination of the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration, this article has also been published in PLoS Medicine. BioMed Central 2012-05-29 /pmc/articles/PMC3362748/ /pubmed/22642691 http://dx.doi.org/10.1186/1741-7015-10-51 Text en Copyright ©2012 Altman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Correspondence Altman, Douglas G McShane, Lisa M Sauerbrei, Willi Taube, Sheila E Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
title | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
title_full | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
title_fullStr | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
title_full_unstemmed | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
title_short | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
title_sort | reporting recommendations for tumor marker prognostic studies (remark): explanation and elaboration |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362748/ https://www.ncbi.nlm.nih.gov/pubmed/22642691 http://dx.doi.org/10.1186/1741-7015-10-51 |
work_keys_str_mv | AT altmandouglasg reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration AT mcshanelisam reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration AT sauerbreiwilli reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration AT taubesheilae reportingrecommendationsfortumormarkerprognosticstudiesremarkexplanationandelaboration |